Forging Success in Type 2 Diabetes: Treatment & Reversal of T2D & Interrogating Cross-Talk in Metabolic Syndrome

Time: 4:30 pm
day: Day One


  • Investigating cross talk in metabolic syndrome: from T2D to obesity to NASH
  • Does T2D represent an attractive path to market? Understanding market access with opportunities and implications in NASH and obesity
  • Pioneering a new generation of gut-targeted polymer therapies to achieve pharmacologic duodenal exclusion: targeting the root cause of metabolic syndrome, improving blood glucose, and examining future potential in obesity and NASH